Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page history now shows a new revision label v3.5.4, replacing the previous v3.5.3. This reflects a new build of the page history rather than changes to the study data or text.
    Difference
    0.1%
    Check dated 2026-05-17T09:59:27.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than any change to the underlying study or its details.
    Difference
    0.1%
    Check dated 2026-04-24T22:40:14.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - Added Revision: v3.5.2. - Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:15:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3 from the version history.
    Difference
    0.1%
    Check dated 2026-03-19T23:41:37.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T19:49:34.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    A new revision v3.4.2 was added to the study record history, replacing the previous v3.4.1. This update is a metadata-level change and does not alter substantive study data or results.
    Difference
    0.1%
    Check dated 2026-02-12T01:50:32.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.